down arrow

Senores Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0RB801010
  • NSEID: SENORES
  • BSEID: 544319
INR
550.80
34.6 (6.7%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 5.95 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Rs cr
Consolidate Quarterly Results
Dec'24
Dec'23
Net Sales
103.02
78.70
Other Operating Income
0.00
0.00
Total Operating income
103.02
78.70
Raw Material Cost
23.10
6.66
Purchase of Finished goods
22.13
43.03
(Increase) / Decrease In Stocks
-4.53
-1.37
Employee Cost
19.01
8.17
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
17.62
7.06
Total Expenditure (Excl Depreciation)
77.33
63.55
Operating Profit (PBDIT) excl Other Income
25.69
15.15
Other Income
5.16
0.80
Operating Profit (PBDIT)
30.85
15.95
Interest
6.16
2.45
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
24.69
13.50
Depreciation
4.20
3.25
Profit Before Tax
20.49
10.25
Tax
4.06
3.14
Provisions and contingencies
0.00
0.00
Profit After Tax
16.43
7.11
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
16.43
7.11
Share in Profit of Associates
0.00
0.00
Minority Interest
-0.75
0.01
Other related items
0.00
0.00
Consolidated Net Profit
17.18
7.10
Equity Capital
46.05
29.95
Face Value
10.0
10.0
Reserves
0.00
0.00
Earnings per share (EPS)
3.73
2.37
Diluted Earnings per share
5.04
3.47
Operating Profit Margin (Excl OI)
24.94%
19.25%
Gross Profit Margin
23.97%
17.15%
PAT Margin
15.95%
9.03%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2024 is 7.63%

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 435.00%

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2024 is -356.60%

stock-summary

Interest

QoQ Growth in quarter ended Dec 2024 is 302.99%

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2024 has fallen from Dec 2023

Compare Quarterly Results Of Senores Pharma. With
Markets Mojo
Figures in Rs cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
103.02
3,230.00
-3,126.98
-96.81%
Other Operating Income
0.00
0.00
0.00
Total Operating income
103.02
3,230.00
-3,126.98
-96.81%
Raw Material Cost
23.10
536.11
-513.01
-95.69%
Purchase of Finished goods
22.13
387.30
-365.17
-94.29%
(Increase) / Decrease In Stocks
-4.53
11.81
-16.34
-138.36%
Employee Cost
19.01
709.71
-690.70
-97.32%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
17.62
755.27
-737.65
-97.67%
Total Expenditure (Excl Depreciation)
77.33
2,400.20
-2,322.87
-96.78%
Operating Profit (PBDIT) excl Other Income
25.69
829.80
-804.11
-96.90%
Other Income
5.16
77.32
-72.16
-93.33%
Operating Profit (PBDIT)
30.85
907.12
-876.27
-96.60%
Interest
6.16
220.93
-214.77
-97.21%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
24.69
686.19
-661.50
-96.40%
Depreciation
4.20
192.30
-188.10
-97.82%
Profit Before Tax
20.49
497.33
-476.84
-95.88%
Tax
4.06
112.81
-108.75
-96.40%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
16.43
381.08
-364.65
-95.69%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
16.43
381.08
-364.65
-95.69%
Share in Profit of Associates
0.00
3.44
-3.44
-100.00%
Minority Interest
-0.75
4.29
-5.04
-117.48%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.18
380.23
-363.05
-95.48%
Equity Capital
46.05
40.06
5.99
14.95%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
3.73
9.49
-5.76
-60.70%
Diluted Earnings per share
5.04
9.44
-4.40
-46.61%
Operating Profit Margin (Excl OI)
24.94%
25.69%
0.00
-0.75%
Gross Profit Margin
23.97%
21.24%
0.00
2.73%
PAT Margin
15.95%
11.90%
0.00
4.05%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 9.59 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in quarter ended Dec 2024 is 7.63%

Quarterly - Standalone Net Profit
Standalone Net Profit 1.07 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in quarter ended Dec 2024 is 435.00%

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -2.42 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in quarter ended Dec 2024 is -356.60%

Quarterly - Interest
Interest 2.70 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in quarter ended Dec 2024 is 302.99%

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -25.23%
in Dec 2024

Figures in Rs %
stock-summary

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023